Clinical Trials Browser

Phase 1 × Solid Tumor × MEK inhibitor I × Clear all

NCT02968485 2019-01-15

Phase I Study of SHR7390 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor